Evidence map›Paper›PMID 31785054›Full record

ArticleHead & neck2020

Long-term opioid use in curative-intent radiotherapy: One-Year outcomes in head/neck cancer patients.

Leif-Erik D Schumacher, Zoukaa B Sargi, Melissa Masforroll, Deukwoo Kwon, Wei Zhao, Maria A Rueda-Lara, Laura M Freedman, Nagy Elsayyad, Stuart E Samuels, Matthew C Abramowitz and 1 more

Open access · greenAbstract read
In one paragraph

Article in Head & neck, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Unveiling Prescribing Patterns: A Systematic Review of Chronic Opioid Prescriptions After Head and Neck Cancer Surgeries.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Pooled it
  2. Article
  3. Long-term opioid use in patients treated with head and neck intensity-modulated radiotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Leif-Erik D SchumacherMiller School of Medicine, University of Miami, Miami, Florida.ORCID 0000-0002-0853-6868
Zoukaa B SargiDepartment of Otolaryngology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.
Melissa MasforrollFlorida International University, Miami, Florida.
Deukwoo KwonDepartment of Public Health Sciences, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.
Wei ZhaoDepartment of Public Health Sciences, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.
Maria A Rueda-LaraDepartment of Psychiatry, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.
Laura M FreedmanDepartment of Radiation Oncology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.
Nagy ElsayyadDepartment of Radiation Oncology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.
Stuart E SamuelsDepartment of Radiation Oncology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.
Matthew C AbramowitzDepartment of Radiation Oncology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.
Michael A SamuelsDepartment of Radiation Oncology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.
University of Miami · USFlorida International University · US

Funding

Tumor Biology Research ProgramP30CA240139 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Kerry L Burnstein · 2019 to 2026
$24.1M
NCI NIH HHS P30 CA240139
6 · The paper itself

Abstract

backgroundNo study has determined the incidence of long-term opioid use, or risk factors for long-term use, ≥1 year after radiotherapy.

methodsMedical records of 276 head/neck cancer patients were retrospectively assessed for persistent opioid use 1-year after curative-intent radiotherapy. Numerous potential risk factors were assessed and the physicians' documented reasons for continued use were qualitatively categorized as suspected opioid use disorder (OUD) or as medically indicated for control of ongoing pain.

resultsOf note, 20 of 276 patients continued using opioids long-term. High maximum opioid dose and the use of opioids and/or psychotropics/non-opioid analgesics at the radiation oncology intake visit were associated with this outcome. Three patients continued due to suspected OUD and 17 due to medical indications.

conclusionOf note, 7.2% of patients developed long-term opioid use, which was associated with high maximum opioid dose and early initiation of opioids and/or psychotropics/non-opioid analgesics. Physicians cited medical indications as the primary reason for continued use.

Indexed as

Head and Neck NeoplasmsOpioid-Related DisordersRadiation OncologyAnalgesics, OpioidHumansRetrospective StudiesAnalgesics, Opioidabusecancercurativelong-termopioid

Identifiers

PMID31785054
PMCPMC7703799
OpenAlexW2990379573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.